Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

actelion

Sanofi eyes Actelion merger as J&J backs down

December 14, 2016 Medical Communications, Research and Development, Sales and Marketing Actelion, Johnson & Johnson, Sanofi

After days of negotiations, Johnson and Johnson has stepped down from its attempts to acquire Swiss blood-pressure specialist Actelion, while …
News
barack-obama-1174489_960_720

Obama seals $6.3 billion 21st Century Cures Act

December 14, 2016 Medical Communications, Research and Development Biden, Obama, US, congress

President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …
News

Lilly offers insulin at 40% discount

December 13, 2016 Research and Development, Sales and Marketing Blink Health, Eli Lilly

Eli Lilly has announced that it will offer its insulin medication, including Humalog, at a 40% discount for eligible patients …
News

Specialist medical education company, Wave, has made six new appointments to reflect the growth in their business over the last 3 months.

December 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Becky Robbins, a former Healthcare Analyst at GlobalData, and Lorna Bosdet, formerly Account Executive at Sciterion have joined as Senior …
News
Press release
ceo_david_hallal_image_sqaure_image

Alexion loses CEO & CFO as internal investigation continues

December 13, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion

Alexion Pharmaceuticals has revealed that its CEO David Hallal (pictured) and CFO Vikas Sinha have resigned effective immediately in connection …
Appointment
emma-harvey0006_horizontal

Rare challenges: Meeting patient needs and delivering medical innovation in ultra-rare diseases

December 12, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, ultra rare disease, ultra-rare disease

Dr Emma Harvey, ‎senior medical director at Alexion Pharmaceuticals UK, shares her views on the challenges of working in the …
Feature
basel_site

Phase 3 eye drug combo failure for Novartis

December 12, 2016 Research and Development, Sales and Marketing Novartis, ophthotech

Novartis’ has failed in its attempt to expand the applications of its anti-VEGF eye treatment Lucentis (ranibizumab) after the drug …
News
shutterstock_38078521

AZ and Lilly come together to battle Alzheimer’s

December 9, 2016 Research and Development, Sales and Marketing AZ, lilly

Pharma titans Eli Lilly and AstraZeneca have announced they are to join forces to co-develop a potential Alzheimer’s treatment, currently …
News
mice

Flickering LEDs could light the way for new Alzheimer’s treatment

December 8, 2016 Medical Communications, Research and Development Alzheimer's, Cognito therapeutics, mice

Research to find a potential new treatment for Alzheimer’s was hit a blow late last month, as Eli Lilly discontinued …
News
sicorbio

Teva embroiled in internal bribery investigation

December 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery

Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …
News

Mylan to restructure and slash around 10% of workforce

December 8, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, epipen, job losses

Mylan has submitted a regulatory filing to the Securities and Exchange Commission to announce that it would be potentially cutting …
News

BMS shares promising Opdivo/Yervoy data for advanced bladder cancer

December 8, 2016 Research and Development BMS, Yervoy, opdivo

BMS has revealed new efficacy data on the combination of its immunotherapies Opdivo (nivolumab) and Yervoy (ipilimumab) for the treatment …
News
shutterstock_212432119

New Alzheimer’s research edges closer to treatment & prevention

December 7, 2016 Research and Development Alzheimer's

A new study has shed light on the possible prevention and treatment of Alzheimer’s disease thanks to findings centred on …
News
lisa_anson

AstraZeneca’s Lisa Anson appointed president of ABPI

December 7, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lisa Anson, current president of AstraZeneca UK & Ireland, has been appointed to the position of president of ABPI. Lisa …
Appointment
imbruv_pack

Janssen reveals positive results from longest follow-up of Imbruvica

December 7, 2016 Research and Development AbbVie, Cilag, Janssen, Pharmacyclics, imbruvica

Janssen used the 5th Annual American Society of Hematoly Meeting and Exposition to reveal that a five-year study of Imbruvica …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026